[Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2015].
A total of 292 adverse reactions to veterinary medicinal products were reported during the year 2015. This represents an increase of 9% compared to the previous year (268 reports). Similar to previous years, most of the reactions reported were linked to the use of antiparasitics (55.1%), non-steroidal anti-inflammatory products (8.9%) or antiinfectives (9.3%). The affected animal species were primarily dogs (198 reports) and cats (42 reports), followed by cattle (31 reports) and horses (8 reports). Additional 42 reports were provided within the frame of consultations with Tox Info Suisse in Zürich and involved mainly the excessive intake of flavored tablets. Eight signals were identified from the reports received or the periodic safety update reports. They resulted in revisions of the product information in sections addressing contraindications, adverse reactions or withdrawal times.
Institut für Veterinärpharmakologie und -toxikologie der Universität Zürich.|Swissmedic, Schweizerisches Heilmittelinstitut, Bern.
C
C
Müntener
Institut für Veterinärpharmakologie und -toxikologie der Universität Zürich.|Tox Info Suisse, Zürich.
J
J
Kupper
Institut für Veterinärpharmakologie und -toxikologie der Universität Zürich.
H
H
Naegeli
Swissmedic, Schweizerisches Heilmittelinstitut, Bern.
B
B
Gassner
D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000977:Antiparasitic Agents / Q000009:adverse effects*; D002415:Cats; D002417:Cattle; D004285:Dogs; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology* / Q000517:prevention & control / Q000662:veterinary*; D006736:Horses; D013557:Switzerland / Q000453:epidemiology; D019155:Veterinary Drugs / Q000009:adverse effects*
D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000977:Antiparasitic Agents; D019155:Veterinary Drugs
Antiparasitika,
Unwirksamkeit; Entzündungshemmer; Pharmacovigilance; Signal; anti-inflammatory drugs; antiparasitics; lack of
efficacy; pharmacovigilance; signal